Why Align Technology (ALGN) is a Top Momentum Stock for the Long-Term

Align Technology (ALGN), a leading provider of clear aligner therapy and dental digital services, is highlighted as a compelling investment due to its strong quantitative ratings and recent performance. The company holds a Zacks #2 (Buy) Rank, a VGM Score of B, and an A for Momentum, with shares up 6.8% over the past four weeks. This positive momentum is further supported by three analyst upgrades to its fiscal 2025 earnings estimate, which increased to $10.33 per share, alongside a consistent 3.4% average earnings surprise, positioning ALGN as a notable candidate for investors.

Analysis

Align Technology (ALGN) is presenting strong quantitative signals indicative of positive momentum and favorable analyst sentiment. The company's stock has appreciated 6.8% over the past four weeks, a move supported by fundamental developments. Specifically, three analysts have revised their fiscal 2025 earnings estimates upward within the last 60 days, leading to an increase in the Zacks Consensus Estimate to $10.33 per share. This positive revision trend is complemented by the company's consistent performance, evidenced by an average earnings surprise of +3.4%. These factors contribute to ALGN's designation as a Zacks Rank #2 (Buy), featuring a top-tier Momentum Style Score of 'A' and a solid overall VGM Score of 'B', collectively highlighting it as a stock with strong quantitative characteristics.

Key Decisions for Investors

• Investors with a momentum-based strategy should consider ALGN, given its strong 'A' Momentum Score, recent 6.8% price increase, and upward revisions in earnings estimates.
• The positive trend in fiscal 2025 earnings estimates and a track record of beating earnings by an average of 3.4% suggest that investors should monitor for continued fundamental strength in upcoming financial reports.
• Given the stock's quantitative 'Buy' rating and bullish signals, it may be prudent to review existing positions or consider ALGN for inclusion in a growth-oriented portfolio, while acknowledging the analysis is based on a specific proprietary rating system.